Additionally, Arab et al. found that saxagliptin protected the gastric mucosa from ethanol-evoked gastropathy through NLRP3 inflammasome inhibition and AMPK/mTOR-driven autophagy activation [43]. Here, NLRP3 is linked to stomach disorder.